In contrast, PCK1 is upregulated and oncogenic in tumors originating from non-gluconeogenic organs (CRC, lung cancer, melanoma, breast cancer, pancreatic cancer, and gastric cancer). Here, PCK1 is linked to pancreatic neoplasm.